These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32763463)

  • 1. Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks.
    Abdelazeem AH; Safi El-Din AG; Abdel-Fattah MM; Amin NH; El-Moghazy SM; El-Saadi MT
    Eur J Med Chem; 2020 Nov; 205():112662. PubMed ID: 32763463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects.
    Amin NH; Hamed MIA; Abdel-Fattah MM; Abusabaa AHA; El-Saadi MT
    Bioorg Chem; 2021 Nov; 116():105394. PubMed ID: 34619468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 1,5-diaryl pyrazole-3-carboxamides as selective COX-2/sEH inhibitors with analgesic, anti-inflammatory, and lower cardiotoxicity effects.
    Hendawy OM; Gomaa HAM; Alzarea SI; Alshammari MS; Mohamed FAM; Mostafa YA; Abdelazeem AH; Abdelrahman MH; Trembleau L; Youssif BGM
    Bioorg Chem; 2021 Nov; 116():105302. PubMed ID: 34464816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase.
    Hwang SH; Wagner KM; Morisseau C; Liu JY; Dong H; Wecksler AT; Hammock BD
    J Med Chem; 2011 Apr; 54(8):3037-50. PubMed ID: 21434686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
    Bioorg Chem; 2021 Sep; 114():105122. PubMed ID: 34243075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
    Abdellatif KRA; Abdelall EKA; Fadaly WAA; Kamel GM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):406-412. PubMed ID: 26691756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition.
    Abdel-Aziz SA; Taher ES; Lan P; El-Koussi NA; Salem OIA; Gomaa HAM; Youssif BGM
    Arch Pharm (Weinheim); 2022 Jul; 355(7):e2200024. PubMed ID: 35429006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors.
    Abdellatif KRA; Abdelgawad MA; Labib MB; Zidan TH
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28605057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.
    Abdellatif KR; Fadaly WA; Ali WA; Kamel GM
    J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Pyridazine-Based Cyclooxygenase-2 Inhibitors with a Promising Gastric Safety Profile.
    Khan A; Diwan A; Thabet HK; Imran M; Bakht MA
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32344801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, molecular docking and anti-inflammatory screening of novel quinoline incorporated pyrazole derivatives using the Pfitzinger reaction II.
    El-Feky SA; Abd El-Samii ZK; Osman NA; Lashine J; Kamel MA; Thabet HKh
    Bioorg Chem; 2015 Feb; 58():104-16. PubMed ID: 25590381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
    Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
    Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
    Shen FQ; Wang ZC; Wu SY; Ren SZ; Man RJ; Wang BZ; Zhu HL
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3653-3660. PubMed ID: 28720504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
    Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
    Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and modeling of hybrids from tetrahydro-1H-pyrazolo[3,4-b]quinolines as dual cholinestrase and COX-2 inhibitors.
    Mroueh M; Faour WH; Shebaby WN; Daher CF; Ibrahim TM; Ragab HM
    Bioorg Chem; 2020 Jul; 100():103895. PubMed ID: 32413626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.
    Das Mahapatra A; Choubey R; Datta B
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents.
    Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM
    Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents.
    Hassan GS; Abou-Seri SM; Kamel G; Ali MM
    Eur J Med Chem; 2014 Apr; 76():482-93. PubMed ID: 24607877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX.
    Omar YM; Abdu-Allah HHM; Abdel-Moty SG
    Bioorg Chem; 2018 Oct; 80():461-471. PubMed ID: 29986191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.